Government fund of funds
Development institute of the Russian Federation

Promogen-MAT

Promogen-MAT
Included in the portfolio of the fund: Bioprocess Capital Ventures CE VF
Year of inclusion in the portfolio: 2009
Investment Status: Seeding and initial
Economic Sector: Biotechnology, Medicine and Health Care
Direction of modernization: Medical Equipment and Pharmaceuticals
City: Moscow
The development of a highly effective technology of medicinal drug production on the basis of curative monoclonal antibody – alpha tumour necrosis factor inhibitor to treat rheumatoid arthritis.

Contacts

+7 (495) 974-74-01
Venue: